Eyes By Design - Medicare Optometrist in Watford City, ND

Eyes By Design is a medicare enrolled "Optometrist" provider in Watford City, North Dakota. Their current practice location is 1005 South Main St, Watford City, North Dakota. You can reach out to their office (for appointments etc.) via phone at (701) 444-3221.

Eyes By Design is licensed to practice in North Dakota (license number 443) and it also participates in the medicare program. Eyes By Design is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1205812393.

Contact Information

Eyes By Design
1005 South Main St,
Watford City, ND 58854
(701) 444-3221
(701) 444-2448



Healthcare Provider's Profile

Full NameEyes By Design
TypeFacility
SpecialityOptometrist
Location1005 South Main St, Watford City, North Dakota
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1205812393
  • Provider Enumeration Date: 12/20/2005
  • Last Update Date: 06/27/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 9032251582
  • Enrollment ID: O20100121000172

Medical Identifiers

Medical identifiers for Eyes By Design such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1205812393NPI-NPPES
60340MedicaidND

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 443 (North Dakota)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Eyes By Design acts as a billing entity for following providers:
Provider NameDouglas Morton Nordby
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1972785335
PECOS PAC ID: 8123935798
Enrollment ID: I20100121000164

News Archive

Accentia enters strategic agreement with Baxter to purchase Cytoxan drug

Accentia Biopharmaceuticals, Inc. today announced a strategic agreement with Baxter Healthcare Corporation to provide Accentia with the exclusive, worldwide right to purchase Baxter's cyclophosphamide, which is marketed under the brand name Cytoxan, for the treatment of designated autoimmune diseases including multiple sclerosis.

Study reveals connection between oral sex and oropharyngeal cancer

A wide breadth of behaviors surrounding oral sex may affect the risk of oral HPV infection and of a virus-associated head and neck cancer that can be spread through this route, a new study led by researchers at the Johns Hopkins Kimmel Cancer Center suggests.

Johns Hopkins School of Medicine develops RAALI for healthcare providers

The Johns Hopkins School of Medicine, the nation's leading medical school recipient of research funds from the National Institutes of Health and a recognized center for "Best Practices" by the Accreditation Council for Continuing Medical Education, discussed the development of a unique medical education initiative - the Rheumatoid Arthritis Action Lab Initiative - to give healthcare providers connectivity to much-needed information on rheumatoid arthritis.

Study determines risk of young-onset breast cancer after use of ovulation-stimulating fertility drugs

Women using fertility drugs who did not conceive a 10-plus week pregnancy were at a statistically significant reduced risk of breast cancer compared to nonusers; however, women using the drugs who conceived a 10-plus week pregnancy had a statistically significant increased risk of breast cancer compared to unsuccessfully treated women, but a comparable risk to nonusers, according to a study published July 6 in the Journal of The National Cancer Institute.

Read more Medical News

› Verified 8 days ago

Provider NameMelissa P Hjelden
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1912160540
PECOS PAC ID: 3577639582
Enrollment ID: I20130612000618

News Archive

Accentia enters strategic agreement with Baxter to purchase Cytoxan drug

Accentia Biopharmaceuticals, Inc. today announced a strategic agreement with Baxter Healthcare Corporation to provide Accentia with the exclusive, worldwide right to purchase Baxter's cyclophosphamide, which is marketed under the brand name Cytoxan, for the treatment of designated autoimmune diseases including multiple sclerosis.

Study reveals connection between oral sex and oropharyngeal cancer

A wide breadth of behaviors surrounding oral sex may affect the risk of oral HPV infection and of a virus-associated head and neck cancer that can be spread through this route, a new study led by researchers at the Johns Hopkins Kimmel Cancer Center suggests.

Johns Hopkins School of Medicine develops RAALI for healthcare providers

The Johns Hopkins School of Medicine, the nation's leading medical school recipient of research funds from the National Institutes of Health and a recognized center for "Best Practices" by the Accreditation Council for Continuing Medical Education, discussed the development of a unique medical education initiative - the Rheumatoid Arthritis Action Lab Initiative - to give healthcare providers connectivity to much-needed information on rheumatoid arthritis.

Study determines risk of young-onset breast cancer after use of ovulation-stimulating fertility drugs

Women using fertility drugs who did not conceive a 10-plus week pregnancy were at a statistically significant reduced risk of breast cancer compared to nonusers; however, women using the drugs who conceived a 10-plus week pregnancy had a statistically significant increased risk of breast cancer compared to unsuccessfully treated women, but a comparable risk to nonusers, according to a study published July 6 in the Journal of The National Cancer Institute.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Eyes By Design is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Eyes By Design
1005 South Main St,
Watford City, ND 58854

Ph: (701) 444-3221
Eyes By Design
1005 South Main St,
Watford City, ND 58854

Ph: (701) 444-3221

News Archive

Accentia enters strategic agreement with Baxter to purchase Cytoxan drug

Accentia Biopharmaceuticals, Inc. today announced a strategic agreement with Baxter Healthcare Corporation to provide Accentia with the exclusive, worldwide right to purchase Baxter's cyclophosphamide, which is marketed under the brand name Cytoxan, for the treatment of designated autoimmune diseases including multiple sclerosis.

Study reveals connection between oral sex and oropharyngeal cancer

A wide breadth of behaviors surrounding oral sex may affect the risk of oral HPV infection and of a virus-associated head and neck cancer that can be spread through this route, a new study led by researchers at the Johns Hopkins Kimmel Cancer Center suggests.

Johns Hopkins School of Medicine develops RAALI for healthcare providers

The Johns Hopkins School of Medicine, the nation's leading medical school recipient of research funds from the National Institutes of Health and a recognized center for "Best Practices" by the Accreditation Council for Continuing Medical Education, discussed the development of a unique medical education initiative - the Rheumatoid Arthritis Action Lab Initiative - to give healthcare providers connectivity to much-needed information on rheumatoid arthritis.

Study determines risk of young-onset breast cancer after use of ovulation-stimulating fertility drugs

Women using fertility drugs who did not conceive a 10-plus week pregnancy were at a statistically significant reduced risk of breast cancer compared to nonusers; however, women using the drugs who conceived a 10-plus week pregnancy had a statistically significant increased risk of breast cancer compared to unsuccessfully treated women, but a comparable risk to nonusers, according to a study published July 6 in the Journal of The National Cancer Institute.

Read more News

› Verified 8 days ago


Optometrist in Watford City, ND

Melissa Phyllis Hjelden, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 109 5th St Sw, Watford City, ND 58854
Phone: 701-444-3221    Fax: 701-444-3226
Douglas M Nordby Jr., O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 109 5th Str Sw, Watford City, ND 58854
Phone: 701-444-3221    Fax: 701-444-3226

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.